A 12-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with uncontrolled asthma
2022-06-27
عنوان الدراسة
A 12-week, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of QAW039 when added to standard-of-care asthma therapy in patients with uncontrolled asthma
داعم الدراسة
Novartis
دواء الدراسة
QAW039/Fevipiprant
رقم بروتوكول الدراسة
CQAW039A2316
حالة الدراسة
Completed
موقع الدراسة
KFMC
مرحلة الدراسة
3
评论与建议
如对政府服务有任何咨询或意见,请填写所需信息。